Investing in 1Spatial (LON:SPA) three years ago would have delivered you a 75% gain

[view original post]

Business Wire

Sensorion to Participate in the LifeSci Partners 2nd Annual Genetic Medicines Symposium on June 29, 2022

MONTPELLIER, France, June 24, 2022–Regulatory News: Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, is pleased to announce the participation of CEO Nawal Ouzren in the LifeSci Partners 2nd Annual Genetic Medicines Symposium being held virtually on June 28-29, 2022.